Quick Navigation

Risk of Myocardial Infarction

Research analysis led by Kamal Patel.
All content reviewed by the Examine.com Team. Published: Jun 28, 2017
Last Updated:

Summary of Risk of Myocardial Infarction

Primary Information, Benefits, Effects, and Important Facts

Scientific Information on Risk of Myocardial Infarction

Learn which supplements work (and which don’t) to achieve your health goals

Enter your email to get our free mini-course on supplements.

100% backed by science, we take an independent and unbiased approach to figure out what works (and what's a waste of time and money). Arm yourself with the knowledge needed to make the right choices to improve your health.



Human Effect Matrix

The Human Effect Matrix looks at human studies (it excludes animal and in vitro studies) to tell you what supplements affect risk of myocardial infarction
Grade Level of Evidence
Robust research conducted with repeated double-blind clinical trials
Multiple studies where at least two are double-blind and placebo controlled
Single double-blind study or multiple cohort studies
Uncontrolled or observational studies only
Level of Evidence
? The amount of high quality evidence. The more evidence, the more we can trust the results.
Outcome Magnitude of effect
? The direction and size of the supplement's impact on each outcome. Some supplements can have an increasing effect, others have a decreasing effect, and others have no effect.
Consistency of research results
? Scientific research does not always agree. HIGH or VERY HIGH means that most of the scientific research agrees.
Notes
grade-b Minor Very High See all 3 studies
Mixed evidence, but a possible decrease in the risk of myocardial infarction rates with niacin supplementation (overall mortality from cardiovascular diseases doesn\'t seem to be altered).
grade-c - - See study
The risk of myocardial infarction (as well as other heart conditions such as angina) does not appear to be significantly affected by ginkgo supplementation.
grade-c - - See study
Vitamin E does not appear to reduce the incidence rates of myocardial infarctions despite a reduction in cardiovascular disease mortality.